The Effect of Real Time Continuous Glucose Monitoring in Subjects With Pre-diabetes

Walter Reed National Military Medical Center110 enrolled

Overview

This study will investigate whether real-time continuous glucose monitoring can be used as a tool for behavior change in people with pre-diabetes.

The protocol is a prospective, non-blinded, randomized controlled study in persons with newly diagnosed pre-diabetes comparing the effects of real-time continuous glucose monitoring (RT-CGM) combined with diet and lifestyle education to those who have diet and lifestyle education alone. During a "wash-in" phase both groups will wear a masked CGM for 1 week at baseline and again after 12 weeks. Those randomized to the RT-CGM will wear it for 4 cycles of 2 week on/1 week off over the next 12 weeks. Both groups will follow-up with their primary care providers as clinically indicated over the next year with quarterly measurements of blood pressure, weight, and BMI. At the end of this period, they will wear a masked CGM for 1 week.

Study Type

INTERVENTIONAL

Allocation

Purpose

PREVENTION

Masking

NONE

Enrollment

110

Conditions

Pre-diabetes Impaired Glucose Tolerance

Interventions

RT-CGMBEHAVIORAL

Dexcom Seven+

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age 18 or older * Newly diagnosed with pre-diabetes (within the previous 6 months) with a FPG of \> or = 110-125mg/dl or an A1c \> or = 6% - 6.4% * Able to independently measure and read finger stick blood glucose levels * Willing to wear the CGM device for up to 12 weeks during the study period * Willing to test blood sugar by fingerstick twice per day while wearing the CGM * DEERS eligible Exclusion Criteria: * Using medication for pre-diabetes * Women who are pregnant, lactating, planning to become pregnant, or without a safe contraceptive method; all female subjects will undergo pregnancy testing via a serum HcG with their initial blood testing. * Subjects who are taking glucocorticoids, amphetamines, anabolic, or weight-reducing agents during the course of the study. * Active Duty service members likely to be deployed during the 18-month study period.

Locations (1)

Walter Reed National Military Medical Center

Bethesda, Maryland, United States